ctrl K

Lyra Therapeutics Inc. (LYRA)

NASDAQ: LYRA · Real-Time Price · USD

0.11

-0.00 (-1.35%)

At close: May 02, 2025, 3:59 PM

0.11

1.75%

After-hours: May 02, 2025, 05:55 PM EDT

Lyra Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	1.53M	1.56M	1.36M	285K	n/a	n/a	1.24M
Cost of Revenue	471K	n/a	1.07M	1M	95K	27K	n/a
Gross Profit	1.06M	1.56M	296K	-716K	-95K	-27K	1.24M
Operating Income	-96.35M	-67.12M	-56.31M	-43.62M	-22.21M	-16.52M	-7.26M
Interest Income	2.95M	4.5M	1.04M	102K	82K	213K	n/a
Pretax Income	-93.4M	-62.62M	-55.27M	-43.51M	-22.13M	-16.31M	-6.03M
Net Income	-93.44M	-62.68M	-55.28M	-42.41M	-22.05M	-16.09M	-6.03M
Selling & General & Admin	18.5M	19.06M	17.56M	14.21M	9.69M	4.49M	3.53M
Research & Development	43.77M	48.03M	38.8M	29.69M	12.52M	12.03M	4.97M
Other Expenses	35.62M	n/a	1.32M	n/a	n/a	n/a	1.19M
Operating Expenses	97.88M	68.68M	56.35M	43.9M	22.21M	16.52M	8.5M
Interest Expense	n/a	n/a	524K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	97.88M	68.68M	56.35M	43.9M	22.21M	16.52M	8.5M
Income Tax Expense	39K	59K	13K	-1.1M	-82K	-213K	-1.23M
Shares Outstanding (Basic)	65.11M	49.8M	30.24M	12.99M	8.59M	12.92M	6.27M
Shares Outstanding (Diluted)	65.11M	49.8M	30.24M	12.99M	8.59M	12.92M	6.27M
EPS (Basic)	-1.43	-1.26	-1.83	-3.27	-2.57	-1.25	-0.96
EPS (Diluted)	-1.43	-1.26	-1.83	-3.27	-2.57	-1.25	-0.96
EBITDA	-60.26M	-65.25M	-53.92M	-42.61M	-22.11M	-16.49M	-7.18M
EBIT	-60.73M	-65.53M	-54.99M	-43.62M	-22.21M	-16.52M	-7.26M
Depreciation & Amortization	471K	278K	1.07M	1M	95K	27K	82K